Notch Therapeutics Welcomes Deepika Rajesh as VP, Stem Cell Biology & Developmental Immunology
VANCOUVER, BC , April 6, 2022 /PRNewswire/ — Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, is pleased to announce the appointment of Deepika Rajesh as VP, Stem Cell Biology and Developmental Immunology. Dr. Rajesh joins Notch from FUJIFILM Cellular Dynamics, Inc. (FCDI), where she was most […]